| What is the risk‐benefit ratio of long‐term antipsychotic treatment in people with schizophrenia? CU Correll, JM Rubio, JM Kane World Psychiatry 17 (2), 149-160, 2018 | 101 | 2018 |
| Epidemiology of chronic and nonchronic major depressive disorder: results from the national epidemiologic survey on alcohol and related conditions JM Rubio, JC Markowitz, A Alegría, G Pérez‐Fuentes, SM Liu, KH Lin, ... Depression and anxiety 28 (8), 622-631, 2011 | 98 | 2011 |
| Efficacy of 42 pharmacologic cotreatment strategies added to antipsychotic monotherapy in schizophrenia: systematic overview and quality appraisal of the meta-analytic evidence CU Correll, JM Rubio, G Inczedy-Farkas, ML Birnbaum, JM Kane, ... JAMA psychiatry 74 (7), 675-684, 2017 | 96 | 2017 |
| Risk factors for anxiety disorders: common and specific effects in a national sample C Blanco, J Rubio, M Wall, S Wang, CJ Jiu, KS Kendler Depression and anxiety 31 (9), 756-764, 2014 | 91 | 2014 |
| Correlates of intimate partner violence perpetration: results from a National Epidemiologic Survey M Okuda, M Olfson, S Wang, JM Rubio, Y Xu, C Blanco Journal of traumatic stress 28 (1), 49-56, 2015 | 73 | 2015 |
| Examining the course of hallucinatory experiences in children and adolescents: a systematic review JM Rubio, J Sanjuán, L Flórez-Salamanca, MJ Cuesta Schizophrenia research 138 (2-3), 248-254, 2012 | 73 | 2012 |
| Original Research Quality of Life Following Remission of Mental Disorders: Findings From the National Epidemiologic Survey on JM Rubio, M Olfson, L Villegas, G Pérez-Fuentes, S Wang, C Blanco J Clin Psychiatry 74 (5), e445-e450, 2013 | 69 | 2013 |
| Persistence of chronic major depression: a national prospective study M Garcia-Toro, JM Rubio, M Gili, M Roca, CJ Jin, SM Liu, C Bastianoni, ... Journal of affective disorders 151 (1), 306-312, 2013 | 34 | 2013 |
| The latent structure and comorbidity patterns of generalized anxiety disorder and major depressive disorder: a national study C Blanco, JM Rubio, M Wall, R Secades‐Villa, K Beesdo‐Baum, S Wang Depression and anxiety 31 (3), 214-222, 2014 | 31 | 2014 |
| Effect of incident axis I disorders on quality of life JM Rubio, M Olfson, G Pérez-Fuentes, M Garcia-Toro, S Wang, C Blanco The Journal of nervous and mental disease 202 (4), 271, 2014 | 25 | 2014 |
| Duration and relevance of untreated psychiatric disorders, 1: Psychotic disorders JM Rubio, CU Correll The Journal of clinical psychiatry 78 (3), 358-359, 2017 | 17 | 2017 |
| Psychosis breakthrough on antipsychotic maintenance: results from a nationwide study JM Rubio, H Taipale, CU Correll, A Tanskanen, JM Kane, J Tiihonen Psychological medicine 50 (8), 1356-1367, 2020 | 11 | 2020 |
| Psychosis breakthrough on antipsychotic maintenance medication (BAMM): what can we learn? JM Rubio, JM Kane npj Schizophrenia 3 (1), 1-2, 2017 | 11 | 2017 |
| Sexual prejudice among medical students L Florez‐Salamanca, J Rubio Medical education 47 (8), 758-759, 2013 | 11 | 2013 |
| Duration and relevance of untreated psychiatric disorders, 2: nonpsychotic psychiatric disorders and substance use disorders JM Rubio, CU Correll The Journal of clinical psychiatry 78 (4), 464-465, 2017 | 9 | 2017 |
| Reduced all-cause mortality with antipsychotics and antidepressants compared to increased all-cause mortality with benzodiazepines in patients with schizophrenia observed in … JM Rubio, CU Corell Evidence-based mental health 20 (1), e6-e6, 2017 | 6 | 2017 |
| Psychosis relapse during treatment with long-acting injectable antipsychotics in individuals with schizophrenia-spectrum disorders: an individual participant data meta-analysis JM Rubio, G Schoretsanitis, M John, J Tiihonen, H Taipale, D Guinart, ... The Lancet Psychiatry 7 (9), 749-761, 2020 | 5 | 2020 |
| Predictors of psychosis breakthrough during 24 months of long-acting antipsychotic maintenance treatment in first episode schizophrenia R Emsley, L Asmal, JM Rubio, CU Correll, JM Kane Schizophrenia Research, 2019 | 5 | 2019 |
| How and when to use clozapine JM Rubio, JM Kane Acta Psychiatrica Scandinavica 141 (3), 178-189, 2020 | 4 | 2020 |
| Clozapine-related drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a systematic review R de Filippis, P Soldevila-Matías, P De Fazio, D Guinart, I Fuentes-Durá, ... Expert Review of Clinical Pharmacology 13 (8), 875-883, 2020 | 1 | 2020 |
